HomeRCKT • NASDAQ
add
Rocket Pharmaceuticals Inc
Previous close
$6.53
Day range
$5.90 - $6.47
Year range
$4.55 - $26.98
Market cap
632.31M USD
Avg Volume
3.01M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 62.69M | 4.01% |
Net income | -60.33M | -1.12% |
Net profit margin | — | — |
Earnings per share | -0.62 | 3.13% |
EBITDA | -60.33M | -3.41% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 372.34M | -0.22% |
Total assets | 527.70M | -6.82% |
Total liabilities | 64.47M | -12.61% |
Total equity | 463.23M | — |
Shares outstanding | 106.63M | — |
Price to book | 1.50 | — |
Return on assets | -34.02% | — |
Return on capital | -37.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -60.33M | -1.12% |
Cash from operations | -46.94M | -60.00% |
Cash from investing | -37.87M | 73.10% |
Cash from financing | 182.85M | 46,664.45% |
Net change in cash | 98.04M | 157.75% |
Free cash flow | -25.40M | -132.22% |
About
Founded
1999
Headquarters
Website
Employees
299
